Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2149-2158

  Agouridas, Constantin ^a   Bonnefoy, Alain ^a   Chantot, Jean François ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; HMR 3004; JOSAMYCIN; MACROLIDE; PRISTINAMYCIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE; MALE; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0030827227     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2149     Document Type: Article

References (29)

1. Agouridas, C., Y. Benedetti, A. Denis, C. Fromentin, S. Gouin Ambrières, O. Le Martret, and J. F. Chantot. 1994. Ketolides: a new distinct semi-synthetic class of macrolides, abstr. F164, p. 227. in Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Agouridas, C., A. Bonnefoy, and J. F. Chantot. 1994. Ketolides, a new semi-synthetic class of macrolides: in-vitro and in-vivo antibacterial activities, abstr. F168, p. 227. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Agouridas, C., A. Bonnefoy, and J. F. Chantot. 1995. In vitro antibacterial activity of RU 004, a novel ketolide highly active against respiratory pathogens, abstr. F158, p. 140. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Agouridas, C., A. Bonnefoy, K. Braham, P. Collette, M. Guitton, A. Hochet, P. Mauvais, and J. F. Chantot. 1995. RU 64004: uptake by phagocytes, intracellular bioactivity and other immuno-modulatory effects, abstr. F175, p. 143. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Amsterdam, D. 1991. Susceptibility testing of antimicrobials in liquid media, p. 53-105. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
6. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
7. Barry, A. 1991. Procedures and theoretical considerations for testing antimicrobial agents in agar media, p. 1-16. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
8. B phenotype of resistance. J. Antimicrob. Chemother. 40:85-90.
9. Chantot, J. F., J. C. Gasc, S. Gouin d'Ambrieres, and A. Lutz. 1983. New ether oxime derivatives of erythromycin A: preparation and antibacterial activities, abstr. 447, p. 165. In Program and abstracts of the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Chantot, J. F., A. Bryskier, and J. C. Gasc. 1986. Antibacterial activity of roxithromycin: a laboratory evaluation. J. Antibiot. 39:660-668.
11. Cleeland, R., and E. Squires. 1991. Evaluation of new antimicrobials in vitro and in experimental animal infections, p. 739-786. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
12. Courvalin, P., H. Drugeon, J. P. Flandrois, and F. Goldstein (ed.). 1991. Fiches techniques d'étude pratique de la bactéricidie, p. 335-336. In Bactéricidie. Editions Maloine, Paris, France.
13. Dabernat, H., M. Seguy, and C. Delmas. 1995. In vitro activity of RU 004 against Haemophilus influenzae and Moraxella catarrhalis, abstr. F161, p. 141. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Deguchi, K., N. Yokota, M. Koguchi, Y. Suzuki, K. Suzuki, S. Fukayama, R. Ishihara, and S. Oda. 1992. Antibacterial activity of rokitamycin against fresh clinical isolates. Jpn. J. Antibiot. 45:1609-1621.
15. Ednie, L., S. K. Sprangler, M. R. Jacobs, and P. C. Appelbaum. 1997. Susceptibilities of 228 penicillin-and erythromycin-susceptible and resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrob. Agents Chemother. 41:1033-1036.
16. Fernandes, P. B., R. Bailer, R. Swanson, C. W. Hanson, E. McDonald, N. Ramer, D. Hardy, N. Shipkowitz, R. R. Bower, and E. Gade. 1986. In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob. Agents Chemother. 30:865-873.
17. Fremaux, A., G. Sissia, J. F. Chantot, and P. Geslin. 1995. Antibacterial activity of the ketolide RU 004 against multi-resistant pneumococci, abstr. F160, p. 141. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. Geslin, P., A. Frémaux, G. Sissia, C. Spicq, and A. Aberrane. 1994. Epidémiologie de la résistance aux antibiotiques de Streptococcus neumoniae en France. Réseau national de surveillance (1983-1994). Med. Mal. Infect. 24:948-961.
19. Hara, K. 1987. New antimicrobial agents series. XXVII. Rokitamycin. Jpn. J. Antibiot. 40:1851-1860.
20. Horodniceanu, T., L. Bouguerlet, and F. Delbos. 1979. Phenotypic aspects of resistance to macrolides and related antibiotics in β-haemolytic group A, B, C and G streptococci, p. 122-131. In Recent developments in laboratory identification techniques, Uppsala. Excerpta Medica, Amsterdam, The Netherlands.
21. Hyder, S. L., and M. M. Streitfeld. 1973. Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes. Antimicrob. Agents Chemother. 4:327-331.
22. Jamjian, C., D. J. Biedenbach, and R. N. Jones. 1997. In vitro evaluation of a novel ketolide antimicrobial agent. RU 64004. Antimicrob. Agents Chemother. 41:454-459.
23. Jorgensen, J. H., J. S. Redding, L. A. Maher, and A. W. Howell. 1987. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J. Clin. Microbiol. 25:2105-2113.
24. Litchfield, J. T., and F. Wilcoxon. 1949. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99-113.
25. Retsema, J., A. Girard, W. Schelkly, M. Manousos, M. Anderson, G. Bright, R. Borovoy, L. Brennan, and R. Mason. 1987. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob. Agents Chemother. 31:1939-1947.
26. Rosato, A., and R. Leclercq. 1995. Regulation of the msrA gene responsible for inducible resistance to erythromycin by active efflux in Staphylococcus epidermidis, abstr. C112, p. 59. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
27. Roussel UCLAF. Brevet Européen 0 676 409 (Priorité française 08.04.94).
28. Schulin, T., C. B. Wennersten, R. C. Moellering, Jr., and G. M. Eliopoulos. 1997. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria. Antimicrob. Agents Chemother. 41:1196-1202.
29. Vicarini, H. 1995. Analyse des régions régulatrices des gènes de résistance à l'érythromycine chez les streptocoques producteurs de méthylase. DEA de Microbiologie, Université Paris 7 Denis Diderot, Paris, France.